Aplantex has been created by a team of entrepreneurs and scientific specialists after a careful validation of the technical concept first formulated in 2019. With the support of our academic and industrial partners, we are now aiming at producing a large catalog of high value plant-based active ingredients to be used within the pharmaceutical, cosmetics and agri-food markets. Our proprietary technology builds on the latest scientific developments in the "omics" field, with a practical, low cost and easily scalable industrial approach. By mastering, redirecting and optimizing the metabolism of our photosynthetic phytoreplicators, we are building the industrial capacity to supply the phytochemical ingredients' market with any valuable product required by our clients.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 3 Place Du Commerce, 500,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://aplantex.ca/en/
- Keywords
- Laval.
- HQ
- Montreal, Quebec
Aplantex Questions
Aplantex's website is http://aplantex.ca/en/
Aplantex's LinkedIn profile is https://ca.linkedin.com/company/aplantexbio
Aplantex has
14 employees.
View email and phone details for 14
employees at Aplantex.
Aplantex's industry is
Pharmaceutical Manufacturing
Aplantex's top competitors are
Cycle Momentum,
Pivot,
Cryos Technologies Inc.,
Altasciences,
Hub6 Inc.,
Probiotech International Inc.,
Blaise Transit,
Circular Innovation Fund,
Nanomox,
Antalya Capital.
Aplantex's categories are Pharmaceutical Manufacturing
Aplantex's founding year is 2019
